Treatment effect of topical fluconazole nanoparticles on Tinea versicolor

Phase 2

• Conditions: Tinea versicolor.; Pityriasis versicolor; B36.0

• Registration Number: IRCT20120707010203N10
• Lead Sponsor: Mazandaran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2021

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Clinical feature of Tinea versicolor
Positive Smear test

Exclusion Criteria

Liver disease
Nephrotic disorders
Diabetes
Malignant disease
Pregnancy
Breast feeding
anti-fungal treatment in recent one months
Sore or damage in infected area

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Skin lesion area. Timepoint: At the beginning of study (time zero) and 2, 4 and 8 weeks after treatment. Method of measurement: Clinical evaluation and smear test.